Aehr Test Systems (NASDAQ:AEHR) Upgraded at William Blair

Aehr Test Systems (NASDAQ:AEHRGet Free Report) was upgraded by equities researchers at William Blair from a “market perform” rating to an “outperform” rating in a report released on Monday, Marketbeat Ratings reports.

A number of other analysts have also recently commented on AEHR. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Aehr Test Systems in a research note on Wednesday, January 21st. Zacks Research upgraded shares of Aehr Test Systems from a “strong sell” rating to a “hold” rating in a report on Monday, December 8th. Craig Hallum reissued a “hold” rating on shares of Aehr Test Systems in a research report on Friday, January 9th. Finally, Lake Street Capital started coverage on shares of Aehr Test Systems in a research report on Wednesday, December 17th. They issued a “buy” rating for the company. Two equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Aehr Test Systems presently has an average rating of “Hold” and an average target price of $21.00.

View Our Latest Stock Report on Aehr Test Systems

Aehr Test Systems Price Performance

Shares of NASDAQ AEHR opened at $37.43 on Monday. Aehr Test Systems has a fifty-two week low of $6.27 and a fifty-two week high of $43.13. The firm has a market capitalization of $1.15 billion, a P/E ratio of -124.76 and a beta of 2.31. The company’s 50 day simple moving average is $27.30 and its 200 day simple moving average is $25.80.

Aehr Test Systems (NASDAQ:AEHRGet Free Report) last posted its quarterly earnings results on Thursday, January 8th. The semiconductor company reported ($0.04) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.04. Aehr Test Systems had a negative return on equity of 4.57% and a negative net margin of 16.63%.The company had revenue of $9.88 million for the quarter, compared to the consensus estimate of $11.45 million. Sell-side analysts expect that Aehr Test Systems will post 0.1 EPS for the current fiscal year.

Insider Transactions at Aehr Test Systems

In other Aehr Test Systems news, Director Laura Oliphant sold 4,546 shares of Aehr Test Systems stock in a transaction dated Thursday, January 22nd. The stock was sold at an average price of $31.40, for a total value of $142,744.40. Following the sale, the director owned 18,432 shares of the company’s stock, valued at $578,764.80. This trade represents a 19.78% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Rhea J. Posedel sold 13,998 shares of the company’s stock in a transaction dated Friday, February 13th. The stock was sold at an average price of $30.02, for a total value of $420,219.96. Following the transaction, the director directly owned 456,979 shares of the company’s stock, valued at $13,718,509.58. This represents a 2.97% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 6.80% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in AEHR. William Blair Investment Management LLC bought a new stake in Aehr Test Systems during the 3rd quarter worth about $26,920,000. Wellington Management Group LLP raised its holdings in Aehr Test Systems by 129.9% during the fourth quarter. Wellington Management Group LLP now owns 830,664 shares of the semiconductor company’s stock worth $16,771,000 after acquiring an additional 469,400 shares in the last quarter. Kennedy Capital Management LLC acquired a new position in Aehr Test Systems during the second quarter valued at approximately $5,751,000. Invesco Ltd. grew its stake in Aehr Test Systems by 1,137.2% in the third quarter. Invesco Ltd. now owns 366,570 shares of the semiconductor company’s stock valued at $11,037,000 after purchasing an additional 336,940 shares in the last quarter. Finally, Next Century Growth Investors LLC increased its position in shares of Aehr Test Systems by 99.9% during the 4th quarter. Next Century Growth Investors LLC now owns 552,506 shares of the semiconductor company’s stock worth $11,155,000 after purchasing an additional 276,160 shares during the last quarter. Institutional investors own 69.69% of the company’s stock.

About Aehr Test Systems

(Get Free Report)

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.

Recommended Stories

Analyst Recommendations for Aehr Test Systems (NASDAQ:AEHR)

Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.